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ABSTRACT 
Excitotoxic levels of glutamate represent a 
physiological stress that is strongly linked to 
amyotrophic lateral sclerosis (ALS) and other 
neurological disorders. Emerging evidence 
indicates a role for neurodegenerative disease–
linked RNA-binding proteins (RBPs) in the 
cellular stress response. However, the 
relationships between excitotoxicity, RBP 
function, and disease have not been explored. 
Here, using primary cortical and motor neurons, 
we found that excitotoxicity induced the 
translocation of select ALS-linked RBPs from the 
nucleus to the cytoplasm within neurons. RBPs 
affected by excitotoxicity included TAR DNA-
binding protein 43 (TDP-43) and, most robustly, 
fused in sarcoma/translocated in liposarcoma 
(FUS/TLS). We noted that FUS is translocated 
through a calcium-dependent mechanism and that 
its translocation coincides with striking alterations 
in nucleocytoplasmic transport. Further, 
glutamate-induced up-regulation of glutamate 
ionotropic receptor AMPA type subunit 2 (GRIA2) 
in neurons depended on FUS expression, 
consistent with a functional role for FUS in 
excitotoxic stress. These findings reveal molecular 
links among prominent factors in 
neurodegenerative diseases, namely excitotoxicity, 
disease-associated RBPs, and nucleocytoplasmic 
transport. 
 
INTRODUCTION 
Glutamate is the major excitatory neurotransmitter 
in the central nervous system. Upon release from 
pre-synaptic terminals, relatively low levels of 
glutamate activate metabotropic glutamate 
receptors as well as the ionotropic receptors: α-
amino-3-hydroxy-5-methyl-4-isoxazolepropionic 
acid (AMPA), N-methyl-D-aspartate and kainate, 
for normal neurotransmission. However, excessive  
 http://www.jbc.org/cgi/doi/10.1074/jbc.RA118.005933The latest version is at 
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glutamate exposure overstimulates neurons. This 
causes a massive influx of calcium, which triggers 
an excitotoxic cascade involving oxidative damage 
as well as mitochondrial and ER dysfunction(1). 
Excitotoxicity has been implicated in neuronal 
death and degeneration for various neurological 
conditions, including the fatal neurodegenerative 
disease amyotrophic lateral sclerosis (ALS). 
Pathological evidence for excitotoxity includes 
elevated levels of glutamate in patient 
cerebrospinal fluid as well as aberrant processing 
of the AMPA subunit that controls calcium influx 
at both the transcript (Gria2) and protein 
(Glutamate Receptor 2; GluA2) level in patient 
tissue and disease models (2). Further, ALS-
causing mutations are present in D-amino acid 
oxidase, an enzyme that regulates the degradation 
of the N-methyl-D-aspartate co-agonist, D-serine 
(3). Riluzole, the first FDA approved treatment for 
ALS, is thought to reduce glutamate signaling 
through anti-excitotoxic effects (4). Despite this 
wealth of knowledge and profound disease 
relevance, the biological mechanisms underlying 
the cellular response to excitotoxicity have not 
been fully elucidated. 
 
RNA-binding proteins (RBPs) have emerged as 
relevant factors in neurodegenerative disease 
pathogenesis, particularly in the context of ALS 
and the related disorder, frontotemporal dementia 
(FTD) (5). RBPs belong to a unique class of 
biomolecules that undergo nucleocytoplasmic 
shuttling in response to various stimuli, including 
stress. For instance, the disease-linked RBPs fused 
in sarcoma/translocated in liposarcoma (FUS/TLS 
or FUS), TAR DNA-binding protein 43 (TPD-43) 
and heterogeneous nuclear ribonucleoprotein A1 
(hnRNPA1) all exhibit nuclear egress during 
hyperosmotic stress (6–8). The purpose of this 
translocation is unclear, and may represent a 
functional response to cellular stress (6, 9). In 
support of this notion, cell viability under 
hyperosmotic stress is compromised when FUS 
expression is reduced (6). However, cell stress 
also represents a non-genetic factor that likely 
contributes to neurodegenerative disease 
pathogenesis (9). Indeed, chronic stress may 
contribute to the pathological accumulation of 
TDP-43 and FUS in some cases of ALS and FTD 
(10–14). For example, TDP-43 partitions into the 
insoluble fraction of cultured cells following 
oxidative stress or heat shock (15, 16) and disease-
linked RBPs have been found to aggregate in vivo 
following cerebral ischemia (17). Intriguingly, the 
effects of stress on RBP translocation appear 
selective. While ER stress, oxidative stress and 
heat shock induce the cytoplasmic accumulation of 
TDP-43 and other RBPs (18, 19), these stressors 
fail to elicit a response of FUS (6, 20). Given the 
physiological relevance of excitotoxicity to 
neurodegenerative disease, an important but 
unanswered question is whether excitotoxic stress 
elicits a functional and/or pathological response 
from disease-associated RBPs.  
 
Here, we demonstrate that excitotoxic levels of 
glutamate induce the nuclear egress of several 
ALS- and FTD-linked RBPs, including FUS, 
TDP-43 and hnRNPA1 into the cytoplasm of 
neurons. The nucleocytoplasmic equilibrium of 
FUS was especially sensitive to excitotoxic stress, 
as FUS was found to rapidly and robustly 
accumulate within soma and dendrites of cortical 
and motor neurons under stress. Further, a 
glutamate-induced increase in dendritic Gria2 was 
dependent on FUS, consistent with a role for FUS 
in glutamatergic signaling during the cellular 
response to excitotoxic stress. Our results also 
revealed potentially adverse consequences of 
excitotoxicity, including the translocation of ALS-
linked FUS variants and early signs of 
nucleocytoplasmic transport dysregulation. This 
study therefore demonstrates that excitotoxicity 
can trigger neurodegenerative disease-associated 
phenotypes including cytoplasmic RBP 
accumulation and nucleocytoplasmic transport 
decline.  
 
RESULTS 
 
Excitotoxic levels of glutamate shift the 
nucleocytoplasmic equilibrium of disease-
linked RNA binding proteins.  
To investigate a potential relationship between 
excitotoxicity and neurodegenerative disease-
linked RBPs, we first examined whether 
excitotoxicity affects the nucleocytoplasmic 
equilibrium of a panel of proteins including FUS, 
TDP-43, hnRNPA1 and TATA-Binding Protein-
Associated Factor 15 (TAF15). All four proteins 
have been linked to ALS (5) and FUS, TDP-43 
and TAF15 are also associated with FTD (21). 
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DIV 14-16 primary cortical neurons, the majority 
of which are excitatory, were bath treated with 
excitotoxic and physiologically relevant levels of 
glutamate (22, 23) (10µM; hereon referred to as 
Gluexcito) for 10 minutes followed by a 30-minute 
washout period (Fig. 1A). Immunofluorescence 
was then used to assess the effect of Gluexcito on the 
cytoplasmic to nuclear (C:N) ratio of the 
endogenous RBPs (Fig. 1B-I). Strikingly, the FUS 
C:N ratio significantly increased ~15-fold from 
0.04±0.05 to 0.6±0.3 in response to Gluexcito (Fig. 
1B,F). This increase is likely due to a rapid egress 
of FUS from the nucleus into the cytoplasm, as a 
Western analysis revealed total FUS protein levels 
are unchanged before and after stress (Fig. 
S1A,B). Gluexcito likewise induced a significant 
increase in the C:N ratio of TDP-43 (Fig. 1C,G) 
and hnRNPA1 (Fig. 1D,H), although not to the 
same extent as FUS. Gluexcito did not significantly 
alter the C:N ratio of TAF15 (Fig. 1E,I). As for 
FUS, protein expression levels of TDP-43, 
hnRNPA1 and TAF15 were unaffected by Gluexcito 
(Fig. S1C-F).  
 
In light of the robust response of FUS to Gluexcito, 
we focused our attention on the properties of FUS 
translocation in more detail. First, endogenous 
FUS translocation in response to Gluexcito was 
confirmed using a panel of different anti-FUS 
antibodies (Fig. S2 A,B). We then examined the 
relationship between FUS translocation and 
glutamate concentration. With 10µM glutamate, 
the vast majority of neurons (91.3±11.5%) 
exhibited FUS egress (Fig. 2A,B), whereas <5% 
neurons exhibited translocation at ≤1µM, 
revealing a dependence of FUS localization on 
glutamate concentration (Fig. 2B). Within the time 
course of our experiment (Fig. 1A), a significant 
accumulation of endogenous FUS was also 
detected throughout microtubule associated 
protein 2 (MAP2)-positive dendrites (Fig. 2C,D). 
The response of FUS to Gluexcito appears to be all-
or-none, as lower concentrations of glutamate 
resulted in fewer neurons responding, but with 
similar degrees of FUS egress (Fig. S2C).  
 
Given the toxicity of Gluexcito on neurons 
(22), we interrogated whether the rapid 
and robust accumulation of FUS outside the 
nucleus was simply a consequence of cell death 
and/or loss of nuclear envelope integrity. extent of 
cell death was assessed using the LDH 
cytotoxicity assay, which detects the activity of 
LDH upon its release into the media from dead or 
dying cells. In contrast to neurons treated with 
lysis buffer, there was no evidence of cell death 
for neurons treated with Gluexcito (Fig. 2E). 
Further, Lamin A/C staining revealed an intact 
nuclear envelope in neurons exposed to Gluexcito 
(Fig. 2F). These observations support the premise 
that cytoplasmic FUS accumulation represents a 
cellular response to Gluexcito, rather than a non-
specific consequence of cell death. Moreover, 
RBP translocation appears selective, as TAF15 
(Fig. 1E,I) and the cytoplasmic protein, fragile X 
mental retardation protein (FMRP; Fig. S3A), did 
not change localization following excitotoxic 
insult. It is noteworthy that Gluexcito affects neuron 
morphology at 30 minutes, potentially indicative 
of a stressed state. Anti-MAP2 staining revealed a 
rearrangement of the cytoskeleton; staining was 
more pronounced around the nucleus and 
indicative of dendritic fragmentation (Fig. 1,2). 
Likewise, the nuclear lamina appeared more 
concentrated around the nuclear envelope. This is 
illustrated by the line scan through the nucleus 
(Fig. 2G). Further, nuclear size was significantly 
smaller in stressed neurons (Fig. 2H). As 
expected, neurons exposed to excitotoxic stimuli 
(10 µM, but not 1 µM glutamate) eventually 
undergo cell death within 24 hours of the initial 
insult (22) (Fig. S3 B,D).  
 
Excitotoxic stress induces egress of 
predominately nuclear ALS-linked FUS 
variants.  
Next, we investigated the behavior of ALS-linked 
FUS variants under conditions of Gluexcito. To this 
end, a series of FLAG-HA-tagged FUS variants 
were transiently expressed in neurons and the C:N 
ratio of exogenous FUS was determined in the 
absence and presence of Gluexcito (Fig. 3). In 
addition to wildtype (WT) FUS, we examined: 
H517Q, the only autosomal recessive FUS 
mutation associated with ALS; R521G, 
representing a mutational ‘hot spot’ for ALS-FUS 
(24); and R495X, a particularly aggressive ALS-
linked mutation (20). All of these variants have 
mutations within the nuclear localization sequence 
(NLS), yet the degree to which FUS H517Q and 
R521G mislocalize to the cytoplasm depends on 
their expression level. Near-endogenous levels of 
The  
 at U
niversity of M
assachusetts M
edical C
enter/T
he L
am
ar Soutter L
ibrary on June 26, 2019
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
Excitotoxicity induces nuclear egress of FUS/TLS 
	
	 4 
these variants exhibit a predominately nuclear 
localization in vitro (20) and in vivo (25),  whereas 
overexpression leads to higher levels of 
cytoplasmic mutant FUS (10). In contrast, the 
entire NLS is omitted from the FUS R495X 
variant, which significantly mislocalizes to the 
cytoplasm regardless of expression level (20). 
Here, we observed minimal cytoplasmic 
mislocalization of mutant FUS H517Q and R521G 
without stress, indicating the expression levels of 
these exogenous proteins were below the threshold 
for significant cytoplasmic mislocalization in these 
cells. As expected, FUS R495X exhibited robust 
cytoplasmic mislocalization under basal conditions  
(Fig. 3). In response to Gluexcito, FLAG-HA-FUS 
WT exhibited a significant translocation to the 
cytoplasm as observed for endogenous FUS (Fig 
1A, F). The C:N ratio of FLAG-HA-FUS H517Q 
and R521G also increased significantly with 
Gluexcito, providing evidence that the ALS-linked 
mutations did not interfere with the response of 
FUS to Gluexcito. In the case of FLAG-HA-FUS 
R495X, the C:N ratio was the same with and 
without Gluexcito, potentially indicative of a ‘ceiling 
effect’ in that the normal nucleocytoplasmic 
distribution of R495X-FUS is equivalent to that of 
‘maximally’ redistributed endogenous FUS 
following excitotoxic stress.  
 
Nucleocytoplasmic transport is disrupted in 
response to excitotoxic stress. 
To understand the mechanism(s) underlying 
endogenous FUS egress in response to Gluexcito, we 
began with an examination of nucleocytoplasmic 
transport factors. FUS contains two predicted 
chromosome region maintenance 1 (CRM1)-
dependent nuclear export sequences (NES) within 
the RNA-recognition motif (26). CRM1 is a major 
protein export factor, although whether this 
receptor controls nuclear FUS export is 
controversial (26, 27). To determine if excitotoxic 
FUS egress is CRM1-dependent, we pretreated 
neurons with the CRM1 inhibitor, KPT-330, prior 
to treatment with Gluexcito (28). The CRM1-
dependent NLS-tdTomato-NES shuttling reporter 
was used as a positive control (29). As expected, 
NLS-tdTomato-NES exhibited both a nuclear and 
cytoplasmic localization under basal conditions 
(Glu–, -KPT), whereas the localization of this 
reporter was significantly restricted to the nucleus 
in the presence of KPT-330 (Glu–, +KPT; Fig. 
4A,B). In contrast, KPT-330 had no effect on 
nuclear FUS egress in response to Gluexcito 
(Gluexcito +/-KPT; Fig. 4A,C). Surprisingly, KPT-
330 also failed to fully restrict NLS-tdTomato-
NES to the nucleus under conditions of Gluexcito 
(Fig. 4A,B). Although there was a significant 
decrease in the percentage of cells with 
cytoplasmic NLS-tdTomato-NES in the presence 
of both KPT-330 and Gluexcito (60.1±8.0%) 
compared to Gluexcito alone (98.3±2.6, p=<0.0001), 
these results suggest that CRM1-mediated export 
is dysregulated under conditions of stress (Fig. 
4B). Moreover, while endogenous CRM1 
predominately localizes to the nucleus, 
significantly more cells exhibited altered CRM1 
localization with Gluexcito. CRM1 alterations 
included enhanced cytoplasmic localization and a 
concentration of CRM1 signal around the nuclear 
membrane (Fig. 4D-F). This finding prompted us 
to examine another critical nucleocytoplasmic 
transport factor, Ras-related nuclear protein (Ran). 
Ran is a GTPase that shuttles between the nucleus 
and cytoplasm and, depending on its nucleotide 
bound state, facilitates nuclear export and import 
(30). Indeed, Gluexcito also induced a significant 
change in the nucleocytoplasmic distribution of 
Ran in that a higher percentage of cells exhibited 
enhanced cytoplasmic Ran expression under stress 
(Fig. 4G-I). These changes to CRM1 and Ran 
localization appear to be independent from 
changes in total protein expression as determined 
by a Western blot analysis of both proteins in the 
presence and absence of Gluexcito (Fig. S3D-F). 
Taken together, Gluexcito caused the redistribution 
of critical transport factors and attenuated the 
effects of KPT-330 on CRM1 export.  
 
Excitotoxic FUS egress is calcium dependent. 
Knowing that calcium influx is a critical 
component of excitotoxicity (1), we sought to 
determine whether this signaling chemical is 
required for the response of FUS to excitotoxicity. 
To this end, the calcium chelator, EGTA, was 
included in the neuronal media during the 
experimental time course. Indeed, EGTA 
completely prevented Gluexcito–induced FUS egress 
in primary cortical neurons (Fig. 5A,B). Further, 
application of the calcium ionophore, Ionomycin, 
was sufficient to induce FUS translocation in the 
vast majority (89.0±5.6%) of neurons (Fig. 5C,D). 
In light of our previous finding that hyperosmotic 
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stress induces nuclear FUS egress (6), we 
wondered whether calcium also mediated this 
response. In contrast to Gluexcito, there was no 
effect of EGTA on FUS egress in neurons treated 
with hyperosmotic levels of sorbitol (Fig. 5E,F), 
indicative of distinct mechanisms for FUS egress 
under these stress conditions.  
 
Next, we investigated the effect of calcium on 
FUS localization in primary motor neurons, the 
neuronal cell type predominately affected in ALS. 
Consistent with cortical neurons, the application of 
Ionomycin to DIV 6-8 motor neurons shifted the 
nucleocytoplasmic equilibrium of FUS towards 
the cytoplasm (Fig. S4). Application of the 
glutamatergic agonist, kainic acid, to motor 
neurons also induced a significant increase in the 
C:N ratio of FUS (Fig. 5G,H). Kainic acid is 
known to induce motor neuron excitotoxicity (31) 
and was used here to avoid confounding effects of 
glutamate uptake by astroglia present in the motor 
neuron cultures (32). As observed for MAP2 
staining in cortical neurons under Gluexcito (Fig. 
2A), the cytoskeleton in motor neurons was 
affected by stress. For example, signals 
corresponding to neurofilaments (detected by 
SMI-32; Fig. S4A) and microtubules (detected by 
TUJ1; Fig. 5G and Fig. S4C) were altered and/or 
diminished under stress. Importantly, these treated 
motor neurons were viable as determined by the 
lack of pyknosis (Fig. 5G and Fig. S4). Further, 
cleaved Caspase-3 staining was not detected in 
cells with kainic acid-induced FUS translocation 
but was present in apoptotic cells treated with the 
proteasome inhibitor MG132 (Fig. S4C). 
 
There was a relatively wide range in the C:N ratio 
of FUS in kainic acid treated neurons. For 
example, a sub-population of cells exhibited near 
complete egress of nuclear FUS (Fig. 5G,H), a 
result that was not observed in cortical neurons 
treated with glutamate. Efforts to characterize the 
properties of neurons that have different degrees 
of FUS translocation were hampered by an 
inability to perform live-cell imaging, as a GFP-
tagged version of FUS did not undergo 
cytoplasmic translocation under excitotoxic stress 
(data not shown). We did notice a trend towards 
smaller nuclear area for kainic acid-treated motor 
neurons, as observed for glutamate-treated cortical 
neurons (Fig. 2H), however the former analysis 
did not reach statistical significance (Fig. S4D). 
Addition of EGTA to the media prior to kainic 
acid resulted in only a partial rescue of the FUS 
response; overall there were fewer cells with high 
levels of cytoplasmic FUS (i.e., high C:N ratios), 
yet some cells were insensitive to EGTA under 
these conditions. Nevertheless, our collective 
findings are consistent with a role for calcium in 
modulating the cytoplasmic egress of FUS under 
conditions of excitotoxicity. 
 
Excitotoxic stress represses translation 
independent of FUS expression and stress 
granule formation. 
Translational repression and stress granule 
formation are common cellular responses to stress 
(33, 34). Given that cytoplasmic FUS has been 
linked to both translational regulation (35, 36) and 
stress granule formation (6, 20, 37, 38), we 
investigated both of these processes during 
excitotoxic stress. In contrast to neurons treated 
with sodium arsenite, a stressor known to induce 
the formation of stress granules (20), Gluexcito did 
not induce the formation of Ras GTPase-activating 
protein-binding protein 1 (G3BP1)-positive stress 
granules in neurons (Fig. 6A). Next, protein 
translation was assessed by pulse labeling neurons 
with puromycin, a small molecule that 
incorporates into elongating peptides (39) (Fig. 
6B). As observed by others, Gluexcito treatment 
inhibited global translation (40–42) and lead to a 
reduction in puromycin incorporation (Fig. 6C-E), 
likely through a mechanism involving inhibition of 
the translation elongation factor,  eukaryotic 
elongation factor 2 (eEF2) (41, 43). 
Immunofluorescence detection of puromycin 
revealed a strong correlation between neurons 
exhibiting FUS translocation and translational 
repression; neurons with obvious translocated FUS 
were puromycin-reduced, and vice versa (Fig. 
6C,F). The degree of translational repression 
induced by Gluexcito was comparable to treatment 
with the translational inhibitor, cycloheximide 
(Fig. 6C-F), which did not promote FUS egress 
(Fig. 6C). Given the strong correlation between 
FUS localization and puromycin intensity, we 
investigated whether FUS expression was required 
for translational repression (Fig. 7). Knockdown 
of endogenous FUS with two different shRNAs 
(44) that target FUS (Fig. 7A,B and Fig. S5) had 
no effect on puromycin intensity in the absence or 
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presence of Gluexcito (Fig. 7C-F). Further, there 
was no net difference in puromycin intensity as a 
function of FUS expression between stressed and 
unstressed conditions (determined by comparing 
puromycin intensities between stressed and 
unstressed conditions, for cells with FUS 
expression or with FUS knock-down) (Fig. 7G). 
Following the same FUS knock-down protocol, 
we did not detect a change in cell viability after 
Gluexcito treatment as a function of FUS expression 
(data not shown); FUS knock-down was neither 
protective nor detrimental to the cell under these 
conditions.  
 
Gria2 mRNA is elevated in dendrites following 
excitotoxic insult in a FUS-dependent manner. 
RBPs such as FUS play crucial roles in mRNA 
processing (9). Although FUS expression did not 
affect global protein synthesis (Fig. 7), this 
analysis would not necessarily detect differences 
in the translation of specific transcripts, especially 
those targeted to dendrites for local translation 
(45). Therefore, we investigated whether FUS 
modulates mRNA metabolism following 
excitotoxic insult and focused on Gria2, a 
transcript that is reportedly bound by FUS (46). 
Gria2 mRNA encodes the GluA2 protein subunit 
of the AMPA receptor and has been implicated in 
calcium dyshomeostasis in both ALS (1) and FTD 
(47). Following depolarization, dendritic GluA2 
levels are enhanced (48). Under excitotoxic 
conditions, we uncovered a significant increase in 
Gria2 transcript density by FISH in both the soma 
and dendrites of cortical neurons (Fig. 8, Fig. 
S6A-C). To examine whether this increase in 
Gria2 mRNA density is FUS dependent, 
endogenous FUS levels were knocked down using 
two shRNAs targeting distinct sequences within 
FUS as described for Figure 7 prior to excitotoxic 
treatment. Consistent with previous findings (46), 
reduced FUS expression did not have a significant 
effect on the levels of Gria2 under basal 
conditions, as determined by FISH within the 
neuronal soma and dendrites (Fig. 8B,C). In 
contrast, Gluexcito-induced changes to Gria2 were 
significantly attenuated upon FUS knockdown. 
Dendritic expression of Gria2 was particularly 
sensitive to FUS levels under Gluexcito, as 
knockdown of FUS restored dendritic Gria2 levels 
to baseline (Fig. 8C, D). Within the time course of 
the analysis, we were unable to detect significant 
changes in GluA2 protein levels by Western blot 
analysis of whole cell lysates (Fig. S6D,E). 
Nevertheless, these data show that FUS expression 
is required for Gluexcito-induced changes to Gria2 
localization in neuronal dendrites (Fig. 8).  Indeed, 
Gria2 mRNA was found associated with FUS 
upon FUS immunoprecipitation from neurons 
under both unstressed (Glu-) and stressed (Gluexcito) 
conditions (Fig. 8E). Although FUS was known to 
interact with Gria2 under unstressed conditions, 
this interaction had not been investigated under 
conditions of stress. To investigate the effects of 
ALS-linked mutations on FUS-mediated Gria2 
processing and localization, FLAG-HA-FUS 
constructs were transiently transfected into 
neurons as described for Figure 3. However, in 
contrast to non-transfected neurons (Fig. 8), 
dendritic levels of Gria2 were unaffected by 
Gluexcito in FLAG-HA-FUS WT expressing cells 
(data not shown), possibly a consequence of 
overexpressed FUS WT exerting a dominant 
negative effect. Together, our data suggest that 
wild-type FUS directly affects the subcellular 
localization of Gria2 under Gluexcito, and that the 
role of mutant FUS should be investigated in 
systems with endogenous levels of protein (25). 
 
DISCUSSION 
 
This study uncovered an association between 
disease-linked RBPs and excitotoxicity, a stress 
that has particularly profound effects on the 
nucleocytoplasmic distribution of FUS in both 
cortical (Fig. 1, 2) and motor neurons (Fig. 5). 
There is a compelling body of evidence linking 
glutamate-induced excitotoxicity to 
neurodegenerative diseases, including ALS (1, 2, 
49). For instance, elevated levels of glutamate 
were detected in biological samples from ALS 
patients (50–52). Cell death caused by glutamate 
and calcium dysregulation has also been 
documented in multiple animal and cellular 
models (1, 2, 50, 53–55). The outcomes of this 
study shed new light on the excitotoxicity cascade 
and implicate a role for the ALS/FTD-linked 
protein FUS in this process. 
 
Our results are consistent with a functional role for 
FUS in response to glutamatergic signaling (56) 
rather than a non-specific effect of cell death. 
First, FUS egress precedes cell death (Fig. 2 and 
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Fig. S4C).  Second, there is selectivity with 
respect to proteins that undergo a change in 
cellular localization; the response of FUS is 
particularly robust compared to the other proteins 
assessed in this study (Fig. 1). Third, the effects of 
excitotoxicity on Gria2 depend on FUS expression 
(Fig. 8). FUS binds Gria2 mRNA within introns 
and the 3’ untranslated region (UTR), and Gria2 
splicing is affected by FUS expression under basal 
conditions (46). FUS binding to the 3’UTR of 
Gria2 is thought to occur synergistically with 
microRNAs that modulate Gria2 expression (57). 
Here, we confirmed that FUS binds Gria2 under 
unstressed conditions and show that FUS remains 
associated with Gria2 under conditions of Gluexcito 
(Fig. 8E). Subsequently, Gria2 density was 
enhanced in neuronal dendrites in a FUS-
dependent manner under Gluexcito (Fig. 8B,D). 
These data are consistent with a role for FUS in 
Gria2 nucleocytoplasmic transport. In the absence 
of stress, FUS binds Gria2 (Fig. 8E) and we 
suspect this interaction takes place predominately 
in the nucleus (Fig. 9).  Upon exposure to 
glutamate stress, we posit that Gria2 is transported 
into the dendrites as part of a complex with FUS 
(Fig. 9). Gria2 encodes the GluA2 protein subunit 
of the AMPA receptor. Normally, GluA2 is post-
transcriptionally edited and GluA2-containing 
AMPA receptors are calcium impermeable. As 
such, the calcium permeability of AMPA receptors 
and the susceptibility of neurons to excitotoxicity 
is dependent on GluA2 (1, 58). We speculate that 
the enhanced dendritic density of Gria2 may serve 
to increase the number of calcium impermeable 
(GluA2-containing) AMPA receptors and thereby 
offset calcium influx caused by existing calcium 
permeable (GluA2-lacking) receptors (Fig. 9). 
Accordingly, we expect FUS to serve a protective 
role under conditions of Gluexcito. We suspect that 
the acute toxicity imparted by Gluexcito was too 
strong to detect additional toxicity from FUS 
knock-down, and that this relationship between 
FUS expression and cellular viability could be 
better addressed using in vivo models of chronic 
stress (59). 
 
In ALS, a putative role for FUS under excitotoxic 
stress could be compromised as a result of 
dysregulated Gria2 editing and/or GluA2 
expression (58, 60) particularly in motor neurons 
that rely heavily on AMPA receptor signaling (1, 
2). Although we were unable to determine if Gria2 
processing is affected by exogenous expression of 
ALS-linked FUS, altered expression of genes 
involved in glutamate receptor signaling were 
recently found in humanized mutant FUS mouse 
models. Subsequent bioinformatics analyses 
predict an inhibition of this pathway within mutant 
FUS spinal cord tissues (25). A “loss of nuclear 
FUS function” may also impact gene expression 
under conditions of Gluexcito. For example, FUS 
egress under conditions of hyperosmotic stress 
coincided with altered splicing of a known FUS 
target, sodium voltage-gated channel alpha subunit 
4 (SCN4A) (61). Further, endogenous expression 
of a severely mislocalized FUS variant correlated 
with reduced levels of Gria2 in motor neurons, a 
phenotype that was attributed to both loss of 
nuclear and gain of cytoplasmic functions of the 
mutant protein (57). However, the relationship 
between FUS and Gria2 was not examined under 
conditions of stress in this prior study, nor was the 
effect of FUS expression on Gria2 sub-cellular 
localization. Our data suggests that FUS directly 
influences the localization and expression of 
specific transcripts such as Gria2, but that FUS 
expression does not augment or attenuate global 
protein translation under either stressed or 
unstressed conditions (Fig. 7). It will be of interest 
to identify other genes that are influenced by FUS 
translocation under Gluexcito or hyperosmotic 
stress, and as a function of disease (25, 35, 62).  
 
While investigating the mechanism(s) underlying 
excitotoxic FUS egress, we uncovered changes to 
the CRM1 nuclear export pathway (Fig. 4). 
Inhibition of CRM1-mediated export by KPT-330 
failed to restrict both NLS-tdTomato-NES (Fig. 
4A,B) and FUS (Fig. 4A,C) within the nucleus 
under Gluexcito. Further, CRM1 localization was 
significantly shifted towards the cytoplasm (Fig. 
4D,E). Despite these changes, nucleocytoplasmic 
transport was not completely dysregulated, as a 
partial inhibitory effect of KPT-330 on the 
shuttling reporter was observed (Fig. 4B). Our 
KPT-330 studies suggest that Gluexcito-induced 
FUS egress occurs through a mechanism other 
than active CRM1 export, and could entail passive 
diffusion (26) or alternative transport factors (63). 
Selectivity of RBP egress following Gluexcito may 
stem from differences in nucleocytoplasmic 
shuttling dynamics, which are influenced by 
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multiple factors including binding interactions and 
post-translational modifications (64). An 
interesting area of future study could be to 
elucidate these factors and determine whether they 
are modulated by stress. 
Alterations to CRM1 and Ran localization (Fig. 4) 
under Gluexcito may represent early signs of 
nucleocytoplasmic transport decline. Indeed, 
previous studies show that various forms of stress 
(e.g., excessive calcium influx, oxidative, and 
hyperosmotic stress) cause damage to nuclear 
pores and impair nucleocytoplasmic transport (65–
69). Mice deficient in key astroglial glutamate 
transporters exhibited both nuclear pore 
degradation and motor neuron degeneration (59). 
Moreover, the nucleocytoplasmic transport 
pathway has been implicated in age-related 
neurodegeneration, particularly in the context of 
ALS and FTD (70). While most ALS/FTD-
associated studies have focused on the role of 
mutant proteins in dysregulating 
nucleocytoplasmic transport (30, 70), ALS/FTD-
associated forms of cellular stress (e.g., 
excitotoxicity) may also contribute to 
nucleocytoplasmic transport defects in both 
inherited and sporadic forms of disease. In fact, 
nucleocytoplasmic transport is an emerging area of 
therapeutic development and the CRM1 inhibitor 
KPT-350 is advancing towards ALS clinical trials. 
Partial inhibition of CRM1 is expected to offset 
defects in nuclear import. CRM1 inhibitors have 
had a therapeutic effect in some (70, 71), but not 
all (59, 63), models of neurodegeneration. 
Collectively, the available data support CRM1-
mediated nucleocytoplasmic transport as a viable 
therapeutic target for neurodegenerative disorders. 
However, a combination therapy addressing 
additional effects of stress-induced nuclear pore 
degradation (i.e., calpain inhibitors (59)) may be 
required for a significant therapeutic outcome. 
 
The calcium-mediated response of FUS to Gluexcito 
has additional implications for neurodegeneration, 
including cases of FUS-mediated ALS. For 
instance, motor neurons derived from human 
ALS-FUS induced pluripotent stem cells are 
intrinsically hyperexcitable (72). Further, the 
effects of ALS-linked FUS on calcium-mediated 
motor neuron toxicity is exacerbated by expression 
of the mutant protein in astrocytes (55, 58). Most 
ALS-linked FUS mutations are located within the 
NLS (24) and induce a shift in the 
nucleocytoplasmic equilibrium of the protein 
toward the cytoplasm, where it is believed to exert 
a gain of toxic function (20, 73). As ALS-linked 
variants R521G and H517Q translocate further 
into the cytoplasm under Gluexcito (Fig. 3), we 
predict these and other variants with impaired 
binding to nuclear import factors will accumulate 
in the cytoplasm under conditions of chronic stress 
in vivo (36, 65). Moreover, chronic stress may 
result in nuclear depletion and cytoplasmic 
aggregation of wild-type FUS and TDP-43 in 
sporadic cases as well (13, 14). We propose a 
model whereby FUS and related RBPs play a 
functional role in response to normal stimulation 
and moderate degrees of stress, but that excessive 
or chronic stress severely disrupts their 
nucleocytoplasmic equilibrium and contributes to 
disease pathology (Fig. 9).  
 
EXPERIMENTAL PROCEDURES 
 
Cell Culture and Stress Application 
HEK293-T cells were cultured as described (6). 
All research involving animals for the primary 
neuron cultures described below was reviewed and 
approved by the Institutional Animal Care and Use 
Committee (IACUC) at the University of 
Massachusetts Medical School. Dissociated 
primary cortical neuron cultures were prepared 
using cortices from C57BL/6 embryonic day 14-
15 mice. Embryos were isolated in ice-cold Hanks 
Buffered Saline Solution (Corning 21-023-CV, 
Corning, NY, USA) and the meninges removed. 
Cells were dissociated for 12 minutes in 0.05% 
Trypsin (Invitrogen 25300-054, Carlsbad, CA, 
USA) at 37˚C, diluted in Dulbecco's Modified 
Eagle Medium (Invitrogen 11965118) containing 
10% Fetal Bovine Serum (MilliporeSigma F4135, 
Burlington, MA, USA) and strained with a cell 
strainer before gently pelleting. Cells were then 
resuspended in Neurobasal media (Invitrogen 
21103049), supplemented with 1% Glutamax 
(Invitrogen 35050-061), 1% Pen-strep (Invitrogen 
15140122) and 2% B-27 (Invitrogen 0080085-
SA), and plated at 1.8-2x105 cells/mL on poly-
ornithine (final concentration of 1.5 µg/mL; 
MilliporeSigma P4957) coated plates or 
coverslips. Neuronal cultures were grown under 
standard culture conditions (37°C, 5% CO2/95% 
air) fed every 3-4 days by adding half volumes of 
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supplemented neurobasal media to each well/dish, 
with additional half changes of media occurring 
every other feeding. Unless indicated, during the 
first feeding (DIV 2 or 3) neuron cultures were 
also treated with a final concentration of 0.5-1µM 
Cytosine β-D-arabinofuranoside hydrochloride 
(MilliporeSigma C6645) to inhibit non-neuronal 
cell growth. Experiments were performed day in 
vitro (DIV) 14-16.  
 
Primary motor neurons were isolated from  
embryonic day 12.5 murine spinal cords as 
described (73). Briefly, after dissociation in 0.1% 
trypsin (Worthington LS003707, Columbus, OH, 
USA) at 37°C for 12 minutes, primary motor 
neurons were purified using a 6% Optiprep 
(MilliporeSigma D1556) density gradient and 
plated on glass coverslips coated with 0.5g/L poly-
ornithine and natural mouse laminin (Thermo 
Fisher 23017015, Waltham, MA, USA). Cells 
were grown in glia-conditioned Neurobasal 
medium and supplemented with 2% B27, 2% 
horse serum (MilliporeSigma H1270), and 
10ng/ml BDNF (PeproTech 450-02, Rocky Hill, 
NJ, USA), GDNF (PeproTech 450-44), and CNTF 
(PeproTech 450-50). Primary motor neurons were 
treated on DIV 6-8 with Ionomycin or dimethyl 
sulfoxide and on DIV 8 with kainic acid. For 
glutamate experiments, 100mM glutamate 
(MilliporeSigma G5889) was freshly prepared in 
neurobasal media and diluted using primary 
neuron cultured media to achieve 0.1-10µM 
solutions. To apply stress, neuronal media was 
replaced with glutamate-containing primary 
cultured media or primary cultured media alone 
(glutamate-free control) for 10 minutes. After 10 
minutes, treatment media was replaced with 
primary cultured media for 30 minutes or longer 
depending on the experiment prior to fixation or 
lysate collection. Kainic acid (Abcam ab144490) 
was diluted from 10 mM/ml to 300µM/ml in 
primary cultured media and added to motor 
neurons for 10 minutes followed by a replacement 
with glia-conditioned media for one hour. Stock 
solutions of 5mM Ionomycin (MilliporeSigma 
I9657) or 1M sodium arsenite (MilliporeSigma 
71287) prepared in prepared in dimethyl sulfoxide 
(Corning 25-950-CQC) or water were diluted to 
10µM or 1 mM in primary cultured media, 
respectively, prior to addition to neurons for one 
hour. MG132 was prepared in DMSO and diluted 
to 1µM in neuronal media prior to adding to 
primary motor neurons for 24 hours. Sorbitol 
(MilliporeSigma S6021) was directly dissolved in 
primary cultured media to obtain a final 
concentration of 0.4M and applied to cells for one 
hour. For experiments in which ethylene glycol 
tetraacetic acid (EGTA; MilliporeSigma E3889) 
was added, a 100mM stock was prepared in water, 
diluted to 2mM in primary cultured media, and 
allowed to incubate for 30 minutes prior to use 
during the experimental time course. Translation 
was inhibited with 2µM cycloheximide 
(MilliporeSigma C7698). Neurons were treated 
with 500nM KPT-330 (Cayman Chemical 18127) 
dissolved in water on DIV 13 for 48 hours prior to 
treatment with glutamate as well as during the 
experimental time course. 
 
Immunofluorescence Analysis  
Primary cortical and motor neurons were fixed 
with 4% paraformaldehyde (Fisher Scientific 
AAA1131336, Waltham, MA, USA) at room 
temperature for 15 minutes and permeabilized 
with 0.1-0.2% Triton X-100. Cortical neuron 
immunofluorescence experiments were conducted 
as described (6, 20) using antibodies described in 
Table 1. Primary motor neuron samples were 
blocked in 4% bovine serum albumin for 45 
minutes and hybridized overnight at 4°C with 
primary antibodies (Table 1) and AlexaFluor-
conjugated secondary antibodies (73). 
 
Image Acquisition and Processing  
Primary motor neuron images were imaged using 
a widefield fluorescence microscope (Nikon TiE, 
Melville, NY, USA) equipped with a cooled 
CMOS camera (Andor, South Windsor, CT, 
USA). Primary motor neurons images were 
acquired as Z-stacks (0.2µm step size) using a 60x 
lens. As indicated, fixed primary cortical neurons 
were imaged using a Lecia TCS SP5 II laser 
scanning confocal (Leica Microsystems, Buffalo 
Grove, IL, USA) or Leica DMI6000B microscope 
as described (6). For confocal images of whole 
cells, 12-bit stacks (∆z = 0.25µM steps, zoom = 
3x, n = 23-30 planes) were acquired at 40x with a 
pixel size of 126nm (1024x1024 pixels; 1000Hz). 
For dendrites, 12-bit stacks (∆z = 0.08µM steps, 
zoom = 3x, n = 40-50 planes) were acquired at 63x 
using a pixel size of 80nm (1024x1024 pixels; 
1000Hz). For fluorescence in situ hybridization 
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(FISH), mFUS and somatic puromycin analyses, 
widefield stacks of the entire cell were acquired 
(z=0.2-.25µm) and deconvolved using the LAS AF 
One Software Blind algorithm (10 iterations). All 
neuron images were analyzed using MetaMorph 
software (Molecular Devices Inc., San Jose, CA, 
USA). The background and shading of stacks were 
corrected as described (20). Sum or maximum 
projections were created from corrected stacks for 
downstream analyses. 
 
For the quantification of cytoplasmic to nuclear 
(C:N) ratios, a 20x20 pixel region was applied to 
the nucleus and perinuclear area in the soma for 
each cell (visualized by DAPI and MAP2, 
neuronal nuclei (NeuN), TUJ1 or SMI-32, 
respectively) as well as an area within each image 
that contained no cells (representing background 
fluorescence). Using MetaMorph or ImageJ, the 
integrated intensity for the signal of interest was 
obtained for each region and a ratio of the 
cytoplasmic:nuclear signal was then generated 
following subtraction of background signal. For 
each experiment, the statistical comparison of C:N 
ratios with or without excitotoxic stress was 
completed using average C:N ratios collected from 
≥three independent, biological experiments. For 
the analysis of FUS levels in neuronal dendrites, 
Microtubule-associated protein 2 (MAP2) was 
used to visualize neuronal dendrites and create a 
dendritic mask using MetaMorph. Using the 
MAP2-defined mask, the integrated intensity of 
FUS staining was obtained and used to quantify 
the relative amount of FUS staining in dendrites. 
For the quantification of nuclear area, DAPI 
images were thresholded using MetaMorph and 
the area of individual nuclei per each cell 
obtained. For the quantification of total neurons 
and neurons exhibiting FUS, CRM1 or RAN 
cytoplasmic translocation by immunofluorescence, 
≥10 fields of view were imaged at 40x for each 
condition tested. As indicated by MAP2 or NeuN 
staining, neurons were quantified from images 
with computer assistance from the ‘Cell Count’ 
feature in MetaMorph. To assess the percent 
neurons with protein translocation, cells were 
scored for the presence of cytoplasmic protein 
divided by the total neuron number to generate the 
percent population exhibiting a response. All line 
scan analyses were completed using the Intensity 
Profile feature in ImageJ and plotted using 
GraphPad Prism.  
 
Western Analysis 
Neurons were treated, washed twice with 
phosphate buffered saline and lysed using RIPA 
buffer (Boston BioProducts BP-115-500, Ashland, 
MA, USA) supplemented with protease (Roche 
11836170001, Basel, Switzerland) and 
phosphotase inhibitors (Roche 4906837001). 
Lysates were centrifuged at 19,357 x g for 15 
minutes, after which the supernatant was collected 
and its protein concentration determined using a 
bicinchoninic acid assay (Thermo Scientific Pierce 
23227, Rockford, IL, USA). Lysates were 
subsequently used for Western and densitometry 
analysis as described (44). Gels were loaded with 
8-20µg lysate and GAPDH was used as a loading 
standard to determine relative protein levels. 
Primary antibodies used for analysis are described 
in Table 1; LI-COR (Lincoln, NE, USA) 
secondary antibodies were used as described (44). 
 
Lactate Dehydrogenase (LDH) Analysis 
Neuron toxicity to glutamate was analyzed by the 
LDH assay using the CytoTox 96 Non-
Radioactive Cytotoxicity Assay kit (Promega 
G1782, Madison, WI, USA).  
 
Plasmids and Cloning 
Human cDNA for FLAG-HA-tagged wildtype, 
H517Q, R521G or R495X FUS were cloned into 
the lentiviral vector, pLenti-CMV-TO-Puro-DEST 
(Addgene 670-1, Cambridge, MA, USA) using the 
In-Fusion HD Cloning Plus kit (Clontech 638909, 
Mountain View, CA). To achieve FUS 
knockdown, shRNA sequences (44) were 
packaged using In-Fusion HD cloning into the 
lentiviral backbone, CSCGW2 (a generous gift 
from Dr. Miguel Sena-Esteves, UMMS), which 
contains a green fluorescent protein (GFP)-
reporter expressed under a separate CMV 
promoter. The shRNA targeting sequences were: 
5’-GCAACAAAGCTACGGACAA-3’ (shFUS1) 
and 5’-GAGTGGAGGTTATGGTCAA-3’ 
(shFUS2) as well as the scrambled control 
sequence, 5’-AATTCTCCGAACGTGTCACGT-
3’ (shSC). The shuttling reporter, NLS-tdTomato-
NES (a generous gift from Dr. Martin Hetzer, Salk 
Institute (29)) was cloned into the pLenti-CMV-
TO-Puro-DEST vector backbone (Addgene 670-1) 
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using Gateway BP and LR Clonase reactions 
(Invitrogen 11789020 and 11791020, 
respectively). The shuttling reporter contained an 
NLS sequence (PPKKKRKVQ) and NES 
sequence (LQLPPLERLTL) attached to tdTomato 
by a GGGG linker at the N and C termini, 
respectively.   
 
Transient Expression of ALS-Mutant FUS 
For transient transfection experiments, neurons 
were fed at DIV 6 and transfected with FLAG-
HA-FUS constructs on DIV 7 using NeuroMag 
(Oz Biosciences NM51000, Marseille, France) 
transfection reagents. DNA (1.0µg) and 1.75µL 
NeuroMag (for one 24-well well; 500uL volume) 
were combined in an eppendorf tube and the 
volume adjusted to 50µL with neurobasal media. 
The DNA mixture was allowed to incubate for 20 
minutes before addition to neurons. Neuron 
cultures were then placed on a NeuroMag magnet 
plate (Oz Biosciences MF10096) within the tissue 
culture incubator for 15 minutes to complete 
transfection. Transfected neurons were collected 
for experimental analyses on DIV 14-16.  
 
Lentiviral Production and Application 
High titer lentivirus was prepared as described 
(74). Briefly, HEK-293T cells were individually 
transfected using calcium phosphate with the 
shRNA or NLS-tdTomato-NES constructs 
described along with the packing plasmids: 
CMVdR8.91 plasmid and VSV-G. DNA 
constructs were prepared using by EndoFree Maxi 
Prep (Qiagen 12362, Germantown, MD, USA). 
Three hours after transfection, cell media was 
replaced with Opti-MEM (Invitrogen 31985070) 
and virus was collected in open-top Beckman 
tubes (Beckman Coulter 344058, Brea, CA, USA) 
by ultracentrifugation at 133907 rcf in an SW32Ti 
rotor 72 hours following transfection. Lentivirus 
titer was obtained by the transduction of HEK 
cells with serially diluted lentivirus. Upon titer 
determination, virus was added to DIV 6 non-
cytosine β-D-arabinofuranoside hydrochloride 
treated neurons at an approximate titer of 1.2-1.810 
tu/ml. For all transduction experiments except 
fluorescence in situ hybridization, neurons were 
cytosine β-D-arabinofuranoside hydrochloride 
treated on DIV 7. Transduced neurons were 
collected 9 days post-transduction (DIV 15) for 
analysis.  
 
Puromycin Analysis  
Based on previously described experiments (35), 
4mM stocks of puromycin (Invitrogen, A11138-
03) were prepared in water. Neurons were treated 
with glutamate as described, except that a final 
concentration of 2µM puromycin was added to the 
primary cultured media during the last 15 minutes 
of the ‘washout’ period. As a positive control of 
translational inhibition, 100µg/ml cycloheximide 
(MilliporeSigma C7698) was included throughout 
the experimental time course. Neurons were then 
analyzed by Western or Immunofluorescence 
using an anti-puromycin antibody (Table 1). For 
the analysis of puromycin immunostaining upon 
FUS knockdown, a 20x20 pixel region was placed 
in the soma of GFP-positive cells. Using 
MetaMorph, the integrated intensity of this region 
was obtained and used to quantify relative 
puromycin levels as described for the C:N signal 
intensity analyses above. Similarly, a 20x20 pixel 
region was applied to the neuronal soma to obtain 
integrated intensity values for cytoplasmic FUS 
and puromycin staining. Obtained values for a 
given cell were used for the correlation analysis of 
these variables. 
 
Fluorescence in situ Hybridization (FISH) 
Analysis 
Non-cytosine β-D-arabinofuranoside 
hydrochloride treated neurons were plated on 
coverslips and transduced with shFUS or shSC-
expressing lentivirus on DIV 6 and harvested on 
DIV 15. Following stress application, neurons 
were fixed with fresh 4% paraformaldehyde 
(Fisher Scientific F79-500) diluted in RNAse free 
water (Corning 46-000-CM) for 30 minutes at 
ambient temperature.  FISH labeling was 
completed using a QuantiGene ViewRNA ISH 
Cell Assay Kit (Affymetrix QVC0001, Santa 
Clara, CA, USA) according to the manufacturer’s 
instructions. One exception to the protocol was 
that samples were dehydrated after fixation with 
two-minute incubations in 50%, 70%, and 100% 
ethanol at ambient temperature followed by a 
second addition of 100% ethanol and stored at -
20°C for five days before processing. The Gria2-
Cy3 probe was designed and tested for specificity 
by Affymetrix. For post-FISH 
immunofluorescence staining, after probe labeling, 
coverslips were washed in phosphate buffered 
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saline for five minutes and then blocked and 
processed for immunofluorescence as described 
(75). Coverslips were probed with MAP2 and GFP 
to visualize neurons and transduced cells, 
respectively. For analysis, neurons with at least 2 
dendrites of >50 µm in length that did not 
excessively overlap with other cells were selected. 
Max projections of the imaged z-stacks were 
analyzed using MetaMorph software.  For each 
neuron analyzed, 2-3 dendrites and the cell body 
were assessed for their area and the number of 
mRNA puncta present.  Average dendrite data 
were reported for each cell and 10 cells were 
analyzed per construct/condition. Images were 
prepared for visualization in the figures based 
upon methods previously described (76). 
 
RNA-immunoprecipitation and Quantitative 
PCR. 
Primary cortical neurons were plated on 1.5 
µg/mL poly-ornithine coated 10 cm plates and 
stressed as described above at DIV 13-15. Cells 
were harvested with polysome lysis buffer (100 
mM KCl, 5 mM MgCl2, 10 mM HEPES pH=7, 
0.5% NP40, freshly supplemented with protease 
inhibitors and 200 units RNaseOUT, Invitrogen 
#10777019). Lysates were cleared through 
centrifugation (16,000 xg) for 15 min at 4°C. 
Protein concentrations were determined using the 
BCA protein assay kit (ThermoFisher, #23227). 
Lysates (1 mg total protein) were subjected to 
immunoprecipitation (IP) and 100 µg (10%) of the 
lysates were reserved for ‘input’ samples. 
Magnetic Surebeads protein A (100 µL/per 
condition; BioRad, #1614013) were washed with 
NT2 buffer (50 mM Tris pH7.4, 150 mM NaCl, 1 
mM MgCl2, 0.05% NP40) and charged with 40 µg 
rabbit anti-FUS antibody (Genscript) or 
Chrompure rabbit IgG whole molecule (Jackson 
ImmunoResearch, #011-000-003) for 2 hr at 4°C 
by rotation. Charged beads were washed with NT2 
buffer and 1 mg lysates were incubated with 
charged beads at 4°C overnight by rotation. 
Supernatants were discarded and beads were 
thoroughly washed six times with NT2 buffer. 
Beads were resuspended in 100 µL NT2 buffer 
supplemented with 0.1% SDS and 30 µg 
Proteinase K (Invitrogen, AM2546) and incubated 
for 30 min at 55°C. RNA from both IP and input 
were extracted using TRIzol reagent (Invitrogen, 
#15596026) following the manufacturer’s 
protocol. Reverse transcription was performed 
using iScript Reverse Transcription Supermix 
(BioRad, #170-8841) as per the manufacture’s 
recommendation. Quantitative PCR was 
performed using iTaq Universal SYBR Green 
Supermix (BioRad, #1725122) with PrimePCR 
SYBR mouse GRIA2 probe (BioRad, 
#qMmuCED0047098) on a CFX384 Real-Time 
PCR thermal cycler (BioRad). Ct values were 
acquired through CFX ManagerTM Software and 
data were presented as % input, which is 
calculated as followed: ∆Ct [normalized IP]= Ct 
[IP]- (Ct [input]-log2 [Input Dilution Factor]); % 
input= 2-∆Ct [normalized IP]. 
 
Experimental Design and Statistical Analysis.  
At least n=3 independent biological experiments 
were performed for every statistical analysis with 
GraphPad Prism software; this includes having an 
independent primary neuron preparation for each 
biological experiment. The number of independent 
biological experiments and the statistical test(s) 
performed are explicitly described in the figure 
legends as follows. A Student’s t-test at 95% 
confidence was used when comparing two 
conditions. For more than two conditions, either a 
one-way or two-way ANOVA was used followed 
by the appropriate post-hoc analyses (Tukey’s or 
Dunnett’s). A Pearson correlation coefficient was 
used for correlations analyses. 
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Table 1. Primary Antibodies Used for Immunofluorescence and Western Analyses.  
 
   Antibody Species* Company Dilution/Incubation** 
FUS R Bethyl Laboratories A300-293A (Montgomery, TX, USA) IF: 1/1000 1h or 1/500 O/N 
FUS M Santa Cruz sc-47711 (clone 4H11, Dallas TX, USA) 
IF: 1/200 1h; WB: 1/1000 4˚C 
O/N 
FUS R Genscript (Piscataway, NJ, USA) (in-house) IF: 1/200; WB: 1/1000 4˚C O/N 
FUS M Santa Cruz sc-373698 (H-6) IF: 1/200 1h; WB: 1/1000 4˚C O/N 
FUS R Bethyl Laboratories A300-302A IF: 1/1000 1h or 1/500 O/N 
MAP2 M MilliporeSigma M9942 (clone HM-2) IF: 1/1000 1h 
MAP2-CY3 M MilliporeSigma MAB3418C3 IF: 1/1000 1h 
NeuN M MilliporeSigma MAB377 IF: 1/200 1h 
SMI-32 M Thermo Fisher IF: 1/500 O/N 
Alexa647-anti-
TUBB3 (TUJ1) M Biolegend AA10 IF: 1:500 1h 
Cleaved Caspase-3 R Cell Signaling #9661S IF: 1:400 4˚C O/N 
GAPDH R MilliporeSigma G9545 WB: 1/20,000 4˚C O/N 
GAPDH M MilliporeSigma G8795 WB: 1/2,000 4˚C O/N 
TAF15 R Abcam ab134916 (Cambridge, United Kingdom) 
IF: 1/250 1h, WB: 1/1000 4˚C 
O/N 
hnRNPA1 M MilliporeSigma R4528 IF: 1/1000 1h, WB: 1/2000 4˚C O/N 
TDP-43 M EnCor Biotechnology Inc. MCA-3H8 (Gainesville, FL, USA) 
IF: 1/250 1h, WB: 1/500 4˚C 
O/N 
Lamin A/C M MilliporeSigma SAB4200236 IF: 1/500 1h 
HA R Cell Signaling C29F4 (Danvers, MA, USA) IF: 1/500 1h 
RAN R Bethyl Laboratories A304-297A IF: 1/250 1h 
CRM1 R Bethyl Laboratories A300-469A IF: 1/250 1h 
Puromycin R Fisher Scientific, MABE343MI (clone 12D10) 
IF: 1/250 1h, WB: 1/1000 4˚C 
O/N 
G3BP1 R Proteintech 13057-2-AP (Rosemont, IL, USA) IF: 1/2000 1h 
GFP R Invitrogen A-21311 IF: 1/1000 1h 
GluA2 M MilliporeSigma MAB397 WB: 1/1000 4˚C O/N 
*R = rabbit host; M= mouse host 
**IF = immunofluorescence; WB = Western blot; O/N = overnight  
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Figure Legends 
 
Figure 1. Endogenous FUS robustly translocates to the cytoplasm in response to excitotoxic stress. 
(A) DIV 14-16 primary cortical neurons were bath treated with 10µM glutamate (Gluexcito) for 10 minutes, 
after which the glutamate-containing media was ‘washed out’ and replaced with cultured neuronal media 
for an additional 30 minutes. (B-E) Immunofluorescence and confocal microscopy revealed the cellular 
localization of FUS, TDP-43, hnRNPA1 and TAF15 (green) in the absence and presence of Gluexcito. 
Endogenous RBP staining (green) visualized by a 16-color intensity map (Int) further demonstrates the 
cytoplasmic presence of these proteins. Neurons and dendrites were identified with anti-MAP2 staining 
(red), and nuclei with DAPI (blue). Scale bars = 10µm. (F-I) Quantification of the cytoplasmic to nuclear 
ratio (C:N) from (B-E) was based on fluorescence intensities of the signal in each compartment as 
descried in the Methods. A significant nuclear egress of FUS (F), TDP-43 (G) and hnRNPA1 (H), but not 
TAF15 (I) was observed following Gluexcito treatment (n = 3-4 biological replicates). Black squares 
represent the C:N ratio of individual cells, and error bars correspond to SEM. Experimental means were 
calculated from the average C:N ratio across the individual biological replicates and significant 
comparisons were determined with a Student’s T-test (FUS **p = 0.0013, hnRNPA1 *p = 0.0107, TDP-
43 *p = 0.0185, n.s. = non-significant).   
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Figure 2. Cell viability and nuclear membrane integrity are intact under conditions of Gluexcito that 
promote FUS translocation. (A) Following excitotoxic insult, FUS egress and cytoskeletal 
rearrangements were detected by anti-FUS (green) and -MAP2 (red) staining, respectively. Scale bar = 
40µm. (B, C) Quantification of FUS translocation revealed a dose dependent response to glutamate in 
neurons using a one-way ANOVA and Tukey’s post-hoc test (10µM compared to 1µM ***p = 0.0002, to 
0.1µM ***p = 0.0001, to 0.01µM ***p = 0.0002, and to Glu– ***p = 0.0002; 5µM compared to 0.1µM 
*p = 0.0404, to 0.01µM *p = 0.0426, and to Glu– *p = 0.0451; n = 3 biological replicates). (C) Increased 
dendritic FUS staining (green) was observed by confocal microscopy following excitotoxic stress. 
Dendrites were labeled with anti-MAP2 (red). Scale bar = 10µm.  (D) Quantification of (C). Black 
squares represent the intensity of dendritic FUS staining per cell. Means represent the average of n = 4 
biological replicates (Student’s T-test; *p = 0.0142) normalized to the control (Glu–). (E) Cytotoxicity 
induced by Gluexcito was assessed after the washout period (Fig. 1A) with the LDH assay. In contrast to 
the positive control (neurons treated with lysis buffer; lysed neurons), membrane permeabilization was 
not detected for neurons exposed to Gluexcito. Neurons cultured in the absence of Gluexcito (Glu–) served as 
a negative control. Wells containing only primary neuron cultured medium (PCM) served as a 
background control. Results reflect n = 3 biological replicates analyzed with a one-way ANOVA and 
Tukey’s post-hoc test (for all statistical comparisons ****p<0.0001, n.s. = non-significant). (F) 
Immunofluorescence with anti-Lamin A/C staining (red) and confocal microscopy revealed the nuclear 
envelope was thickened yet still intact within neurons exhibiting translocated FUS (green) after Gluexcito 
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exposure. The time point is the same as (E). Scale bar = 25µm. (G) Representative line scan analyses of 
Lamin staining demonstrates enhanced lamin intensity at the nuclear periphery in neurons exposed to 
excitotoxic insult (scale bars = 10 µm). For (B), (D), (E) and (H), error bars represent SEM. (H) 
Quantification of nuclear size using the nuclear counterstain, DAPI, revealed a significant decrease in 
nuclear area following excitotoxic insult. Black squares represent the area of individual neurons. Means 
represent the average of n = 4 biological replicates (Student’s T-test; *p = 0.0154). 
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Figure 3. The effect of Gluexcito on ALS-linked FUS variants. (A) Cortical neurons transfected with the 
indicated FLAG-HA-tagged FUS variants were exposed to Gluexcito and nuclear FLAG-HA-FUS egress 
was assessed by immunofluorescence. Exogenous FUS was detected using an anti-HA antibody (green) 
within MAP2-positive neurons (red). Nuclei were stained with DAPI (blue). Scale bar = 10µm. (B) 
Quantification of the C:N ratio for FLAG-HA-FUS variants in (A) revealed a significant shift in 
equilibrium towards the cytoplasm for FLAG-HA-FUS WT, H517Q and R521G, but not R495X 
(Student’s T-test; WT ***p = 0.0003, H517Q ***p = 0.0003 , R521G *p = 0.0197, n.s. = not significant, 
n=3-5 biological experiments). However, the C:N ratio of H517Q, R521G and R495X was not 
significantly different from FLAG-HA-FUS WT following Gluexcito treatment, (Glu–; one-way ANOVA 
and Dunnett’s post-hoc test; n.s. = non-significant, n = 3-5 biological replicates). Black squares represent 
individual, cellular C:N measurements. Error bars represent SEM. 
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Figure 4. Nucleocytoplasmic transport is disrupted by Gluexcito. (A-C) Cortical neurons expressing the 
shuttling reporter, NLS-tdTomato-NES, were treated with or without 500 nM of the exportin 1 inhibitor 
KPT-330 (KPT) prior to Gluexcito exposure. Neurons were identified with anti-MAP2 staining (A; red). 
The percentage of MAP2-positive cells expressing cytoplasmic NLS-tdTomato-NES (A; white) or FUS 
(A; green) was quantified in (B) and (C), respectively (n = 3 biological experiments). KPT-330 
effectively prevents NLS-tdTomato-NES from localizing to the cytoplasm in the absence of stress (Glu–; 
two-way ANOVA and Tukey’s post-hoc test; for all statistical comparisons ****p<0.0001), as expected. 
Conversely, in the presence of stress (Gluexcito), KPT-330 fails to restrict NLS-tdTomato-NES and FUS 
localization to the nucleus, indicative of dysregulated nucleocytoplasmic transport (in B and C, compare 
Glu– to Gluexcito in the presence of KPT-330, two-way ANOVA and Tukey’s post-hoc test; for all 
significant statistical comparisons ****p<0.0001, n.s. = non-significant). The localization of nuclear 
transport factors CRM1 (D-F) and RAN (G-I) were significantly altered under conditions of Gluexcito in 
MAP2-positive neurons (red); cytoplasmic CRM1 and RAN (green in D and E, respectively) were more 
apparent in stressed cells. The percentage of neurons with CRM1 or RAN mislocalization were quantified 
in (E) and (H), respectively (Student’s T-test; CRM1 ***p = 0.0006, RAN ***p = 0.0003; n = 3 
biological replicates). Error bars represent SEM. (F, I) Representative line scan analyses of CRM1 and 
RAN staining demonstrates an increase in the cytoplasmic presence of these proteins. Specific to CRM1, 
an increase in staining intensity at the nuclear periphery was observed in neurons exposed to excitotoxic 
insult. Scale bars = 10 µm. 
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Figure 5. Calcium is necessary and sufficient for FUS translocation in primary cortical and motor 
neurons. (A) Reducing extracellular calcium levels with 2mM EGTA attenuates FUS egress (green) in 
MAP2-postive neurons (red) following excitotoxic insult. Nuclei were stained with DAPI (blue).  (B) 
Quantification of confocal microscopy findings in (A) confirmed the effect of EGTA treatment (two-way 
ANOVA and Tukey’s post-hoc test; for all statistical comparisons ****p<0.0001; n = 4 biological 
replicates). (C,D) Application of 10µM of the calcium ionophore, Ionomycin (Iono), for 1 hour induced 
FUS translocation relative to the dimethyl sulfoxide control (Student’s T-test; ****p<0.0001; n=3 
biological replicates). (E,F) FUS translocation induced by hyperosmotic stress (HOS) was not 
significantly attenuated by EGTA treatment (two-way ANOVA and Tukey’s post-hoc test; for all 
significant statistical comparisons ****p<0.0001, n.s. = non-significant; n=3 biological replicates). (G,H) 
A 10-minute treatment of 300µM kainic acid (KA) followed by a 1-hour recovery induced FUS egress in 
primary motor neurons. Neurons were identified using the neuronal marker, TUJ1 (red) and nuclei were 
stained with DAPI (blue). (H) Kainic acid (KA) induced FUS egress was statistically significant relative 
to the washout control, however the addition of EGTA did not significantly restore FUS localization 
(two-way ANOVA and Tukey’s post-hoc test; *p<0.0190, n.s. = non-significant; Control and KA n = 8 
biological replicates, EGTA and KA + EGTA n = 3 biological replicates). Black squares indicate 
 at U
niversity of M
assachusetts M
edical C
enter/T
he L
am
ar Soutter L
ibrary on June 26, 2019
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
Excitotoxicity induces nuclear egress of FUS/TLS 
	
	 27 
individual cell measurements normalized to the average of the replicate control. Accordingly, means 
represent the normalized average of biological replicates.  Error bars represent SEM. Scale bars = 10µm. 
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Figure 6. FUS translocation coincides with translational repression in neurons exposed to Gluexcito. 
(A) Immunofluorescence staining of stress granule marker, G3BP1 (red), shows neurons treated sodium 
arsenite (NaAsO2) form stress granules unlike Gluexcito or Glu– conditions where G3BP1 signal remains 
diffuse. Scale bar = 20µm.  (B) Cellular translation in neurons was monitored by pulse-treatment and 
incorporation of the small molecule, puromycin, into nascent peptides during excitotoxic and/or 
cycloheximide treatment (CHX; inhibitor of protein translation). (C) The localization of FUS (green) and 
incorporated puromycin (magenta) in MAP2-postive neurons (red) was assessed by immunofluorescence. 
Relative to Glu–, protein translation was reduced upon application of cycloheximide or Gluexcito, however 
cycloheximide did not induce FUS egress from nuclei (DAPI; blue). The white arrowhead marks a neuron 
with predominately nuclear FUS and high puromycin staining under Gluexcito, whereas most neurons 
under this condition have cytoplasmic FUS and reduced puromycin staining. White boxes denote higher 
magnification details (right) to highlight neurons with representative levels of translation, as observed by 
anti-puromycin staining. Scale bars = 10µm. (D,E) Western and densitometry analysis of puromycin 
incorporation confirms a significant reduction in translation following cycloheximide or Gluexcito 
treatment relative to Glu– (one-way ANOVA and Tukey’s post-hoc test, for all statistical comparisons 
****p<0.0001, n = 3 biological replicates). Puromycin signal was normalized to total protein levels. Error 
bars represent SEM. (F) Plotting cytoplasmic FUS intensity (x-axis) with puromycin intensity (y-axis) for 
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neurons treated with glutamate (blue) or control conditions (grey), revealed a significant, inverse 
correlation between cytoplasmic FUS and puromycin following excitotoxic insult. Statistical analysis of 
(D) was completed using data from n = 3 biological replicates (Pearson’s correlation coefficient r = -
0.3214, ****p <0.0001, n = 144 neurons).  
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Figure 7. Reduced protein translation following excitotoxic stress is independent of FUS levels. 
Primary neurons were transduced with shRNAs against mouse FUS (shFUS1, shFUS1) or a scrambled 
control (shSC) to induce FUS knockdown. (A, B) Western and densitometry analysis confirms FUS 
knockdown relative to non-transduced (NT) and shSC conditions. A modest increase in FUS levels was 
observed upon expression of shSC relative the loading standard, GAPDH (GAP; n=3; one-way ANOVA 
and Tukey’s Post Hoc test, ****p<0.0001, **p = 0.0020; n=3 biological replicates).  (C, D) Neurons 
were pulse-chased labelled with puromycin (Puro; magenta) to assess nascent protein translation in 
transduced cells (as in B-D). The intensity of puromycin staining (Puro) for each condition was 
normalized to the respective stressed or unstressed non-transduced (NT) control. Scale bar = 10µm. (E,F) 
Quantification of puromycin (Puro) staining from (G,H) reveals no statistical difference in the somatic 
levels of translation following FUS knockdown (shFUS1, shFUS2) relative to shSC (one-way ANOVA 
and Dunnett’s post-hoc test, n.s. = not significant, n = 3 biological replicates). (G) Further, there was no 
significant difference in the relative amount of puromycin intensity between stress and non-stress 
conditions (Gluexcito/Glu–) as a result of FUS levels (shSC, shFUS1 and shFUS2). For stress and non-stress 
conditions, puromycin intensities were normalized to the respective, non-transduced control; black 
squares represent the means represent from n = 3 biological replicates (one-way ANOVA and Tukey’s 
Post Hoc test, n.s. = non-significant). Error bars = SEM. 
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Figure 8. Elevation of Gria2 mRNA in dendrites following Gluexcito requires FUS expression. (A) 
Lentivirus expressing a GFP reporter and scrambled control shRNA (shSC) or shRNA against FUS 
(shFUS1, shFUS2) were used to reduce FUS levels in neurons in order to evaluate Gria2 mRNA 
distribution in soma and dendrites. (B, C) Following excitotoxic insult, the density of Gria2 was increased 
in both (B) soma and (C) dendrites of shSC transduced neurons; upon FUS knockdown dendritic Gria2 
did not increase following treatment with Gluexcito using a two-way ANOVA and Dunnett’s post-hoc test 
(Soma: Glu– shSC vs. Gluexcito shSC *p = 0368, Glu– shFUS2 vs. Gluexcito shSC **p = 0.0050, Gluexcito 
shSC vs. Gluexcito shFUS2 *p = 0.0476; Dendrites: ****p<0.0001, Gluexcito shSC vs. Gluexcito shFUS1 
****p = 0.0001, Gluexcito shSC vs. Gluexcito shFUS2 ****p = 0.0002; n = 3 biological replicates). Black 
squares indicate individual cell measurements. Error bars represent SEM. Scale bars = 10µm. (D) 
Representative images of (B,C). Gria2 mRNA was detected by FISH (white) in neurons outlined in green 
(raw images shown in Fig. 7-1B; image processing described in Fig. 7-1C). (E) The amount of Gria2 
mRNA bound by immunoprecipitated neuronal FUS is not significantly different between stress and non-
stress conditions (Student’s t-test, n.s. = non-significant, n = 3 biological replicates). 
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Figure 9. A model depicting the impact of excitotoxic stress on neuronal homeostasis and disease 
pathogenesis. Under homeostatic conditions, shuttling RBPs such as FUS are predominately localized 
within the nucleus (top). Excitotoxic levels of glutamate (bottom) induce a massive influx of calcium, 
which is sufficient to induce the robust nuclear egress of FUS into the neuronal soma and dendrites. 
Excitotoxic stress also leads to translational repression, a re-distribution of nucleocytoplasmic transport 
factors, and increased levels of Gria2 transcript within dendrites. The expression of FUS is required for 
enhanced levels of dendritic Gria2 in response to excitotoxic stress, implicating an RNA-processing role 
for FUS under these conditions. Enhanced levels of edited Gria2 transcript may represent a mechanism to 
offset the toxic effects of calcium influx. We speculate that prolonged or severe stress could manifest in 
the pathological aggregation of RBPs, including FUS, in neurodegenerative diseases such as ALS and 
FTD. Aberrant processing of Gria2 and/or GluA2 can occur through several mechanisms (e.g., expression 
of mutant FUS in astrocytes, loss of FUS function due to aggregation, and other means as described in the 
text), and contributes to calcium dyshomeostasis during disease.  
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